These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 793779)

  • 21. Effects of piretanide, bumetanide and frusemide on electrolyte and urate excretion in normal subjects.
    Roberts CJ; Homeida M; Roberts F; Bogie W
    Br J Clin Pharmacol; 1978 Aug; 6(2):129-33. PubMed ID: 678389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance.
    Verbrugge FH; Martens P; Ameloot K; Haemels V; Penders J; Dupont M; Tang WHW; Droogné W; Mullens W
    Eur J Heart Fail; 2019 Nov; 21(11):1415-1422. PubMed ID: 31074184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bumetanide: a new loop diuretic (Bumex, Roche Laboratories).
    Halstenson CE; Matzke GR
    Drug Intell Clin Pharm; 1983 Nov; 17(11):786-97. PubMed ID: 6357686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of bumetanide in nephrotic syndrome: a double-blind crossover study with furosemide.
    Lau K; DeFronzo R; Morrison G; Rascoff J; Goldberg M; Agus ZS
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):489-97. PubMed ID: 789411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bumetanide (Burinex) --furosemide (Lasix). A comparative study in congestive heart failure].
    Michalsen H; Stokkeland M; Ditlefsen EM; Sangvik K
    Tidsskr Nor Laegeforen; 1976 Sep; 96(27):1428-9. PubMed ID: 790637
    [No Abstract]   [Full Text] [Related]  

  • 26. Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor.
    van Vliet AA; Donker AJ; Nauta JJ; Verheugt FW
    Am J Cardiol; 1993 Jan; 71(3):21A-28A. PubMed ID: 8422000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Clissold SP; Brogden RN
    Drugs; 1985 Jun; 29(6):489-530. PubMed ID: 3891305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of once-daily versus twice-daily bumetanide in heart failure.
    Hunter KR; Underwood PN
    Postgrad Med J; 1975; 51 Suppl 6():91-95. PubMed ID: 1105538
    [No Abstract]   [Full Text] [Related]  

  • 29. A study of two diuretic/potassium combinations in heart failure.
    Hussain M; Walton K; Davidson C; Morgan DB
    Postgrad Med J; 1985 Jan; 61(711):29-33. PubMed ID: 3991397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosage dependent hormonal counter regulation to combination therapy in patients with left ventricular dysfunction.
    Galløe AM; Skagen K; Christensen NJ; Nielsen SL; Frandsen EK; Bie P; Dalgaard P; Larsen K
    J Clin Pharm Ther; 2006 Apr; 31(2):139-47. PubMed ID: 16635047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diuretic action of bumetanide in advanced chronic renal insufficiency.
    Berg KJ; Tromsdal A; Wideroe TE
    Eur J Clin Pharmacol; 1976 Feb; 9(4):265-75. PubMed ID: 786692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-ranging evaluation of bumetanide pharmacodynamics in critically ill infants.
    Sullivan JE; Witte MK; Yamashita TS; Myers CM; Blumer JL
    Clin Pharmacol Ther; 1996 Oct; 60(4):424-34. PubMed ID: 8873690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral piretanide in chronic renal failure.
    Henderson IS; Beattie TJ; Kennedy AC; Dombey SL
    Br J Clin Pharmacol; 1982 Dec; 14(6):857-60. PubMed ID: 7150461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of the sites and mechanisms of action of bumetanide in man.
    Jayakumar S; Puschett JB
    J Pharmacol Exp Ther; 1977 Apr; 201(1):251-8. PubMed ID: 850144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of ethacrynic acid, bumetanide, frusemide, spironolactone and ADH on electrolyte excretion in ponies.
    Alexander F
    J Vet Pharmacol Ther; 1982 Sep; 5(3):153-60. PubMed ID: 7143552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bumetanide--acute and long-term studies of a new high potency diuretic.
    Murdoch WR; Auld WH
    Postgrad Med J; 1975; 51 Suppl 6():64-69. PubMed ID: 1105535
    [No Abstract]   [Full Text] [Related]  

  • 37. Bumetanide in heart failure in infancy.
    Ward OC; Lam LK
    Arch Dis Child; 1977 Nov; 52(11):877-82. PubMed ID: 413494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative efficacy and safety of bumetanide and furosemide in long-term treatment of edema due to congestive heart failure.
    Dixon DW; Barwolf-Gohlke C; Gunnar RM
    J Clin Pharmacol; 1981; 21(11):680-7. PubMed ID: 7338579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bumetanide in the treatment of congestive heart failure and arterial hypertension].
    Vichi FL; de Oliveira AC; Fariña FR; Bernardes F J; Martins JD; Mazotti L
    Arq Bras Cardiol; 1978 Aug; 31(4):277-80. PubMed ID: 727982
    [No Abstract]   [Full Text] [Related]  

  • 40. Bumetanide: a new diuretic. Results of clinical efficacy and safety in patients with congestive heart failure.
    Handler B; Dhingra RC; Rosen KM
    J Clin Pharmacol; 1981; 21(11):691-6. PubMed ID: 7338580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.